Annual EBITDA
-$16.68 M
+$7.69 M+31.55%
December 31, 2023
Summary
- As of February 8, 2025, VVOS annual EBITDA is -$16.68 million, with the most recent change of +$7.69 million (+31.55%) on December 31, 2023.
- During the last 3 years, VVOS annual EBITDA has fallen by -$5.43 million (-48.31%).
- VVOS annual EBITDA is now -115.84% below its all-time high of -$7.73 million, reached on December 31, 2018.
Performance
VVOS EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$2.50 M
-$708.00 K-39.53%
September 30, 2024
Summary
- As of February 8, 2025, VVOS quarterly EBITDA is -$2.50 million, with the most recent change of -$708.00 thousand (-39.53%) on September 30, 2024.
- Over the past year, VVOS quarterly EBITDA has stayed the same.
- VVOS quarterly EBITDA is now -105.68% below its all-time high of -$1.22 million, reached on June 30, 2020.
Performance
VVOS Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$11.91 M
+$991.00 K+7.68%
September 30, 2024
Summary
- As of February 8, 2025, VVOS TTM EBITDA is -$11.91 million, with the most recent change of +$991.00 thousand (+7.68%) on September 30, 2024.
- Over the past year, VVOS TTM EBITDA has stayed the same.
- VVOS TTM EBITDA is now -315.80% below its all-time high of -$2.87 million, reached on September 30, 2019.
Performance
VVOS TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
VVOS EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +31.6% | 0.0% | 0.0% |
| 3 y3 years | -48.3% | +52.9% | +35.5% |
| 5 y5 years | -115.8% | +22.6% | +1.7% |
VVOS EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +31.6% | -39.5% | +65.0% | at high | +53.5% |
| 5 y | 5-year | -69.0% | +31.6% | -105.7% | +65.0% | -126.8% | +53.5% |
| alltime | all time | -115.8% | +31.6% | -105.7% | +65.0% | -315.8% | +53.5% |
Vivos Therapeutics EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$2.50 M(+39.5%) | -$11.91 M(-7.7%) |
| Jun 2024 | - | -$1.79 M(-50.8%) | -$12.90 M(-16.7%) |
| Mar 2024 | - | -$3.64 M(-8.7%) | -$15.48 M(-7.1%) |
| Dec 2023 | -$16.68 M(-31.6%) | -$3.98 M(+14.2%) | -$16.67 M(-10.3%) |
| Sep 2023 | - | -$3.49 M(-20.1%) | -$18.58 M(-8.6%) |
| Jun 2023 | - | -$4.37 M(-9.5%) | -$20.32 M(-10.2%) |
| Mar 2023 | - | -$4.83 M(-18.1%) | -$22.64 M(-6.8%) |
| Dec 2022 | -$24.36 M(+24.7%) | -$5.89 M(+12.7%) | -$24.28 M(-4.9%) |
| Sep 2022 | - | -$5.23 M(-21.7%) | -$25.52 M(-0.3%) |
| Jun 2022 | - | -$6.68 M(+3.1%) | -$25.60 M(+12.4%) |
| Mar 2022 | - | -$6.48 M(-9.2%) | -$22.79 M(+16.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | -$19.54 M(+73.8%) | -$7.13 M(+34.4%) | -$19.54 M(+5.9%) |
| Sep 2021 | - | -$5.31 M(+37.4%) | -$18.46 M(+25.0%) |
| Jun 2021 | - | -$3.87 M(+19.7%) | -$14.77 M(+21.9%) |
| Mar 2021 | - | -$3.23 M(-46.7%) | -$12.12 M(+7.8%) |
| Dec 2020 | -$11.24 M(+14.0%) | -$6.05 M(+274.4%) | -$11.24 M(+48.4%) |
| Sep 2020 | - | -$1.62 M(+33.1%) | -$7.57 M(-14.1%) |
| Jun 2020 | - | -$1.22 M(-48.4%) | -$8.82 M(+16.0%) |
| Mar 2020 | - | -$2.36 M(-1.3%) | -$7.61 M(+44.9%) |
| Dec 2019 | -$9.87 M(+27.7%) | -$2.39 M(-16.7%) | -$5.25 M(+83.3%) |
| Sep 2019 | - | -$2.87 M | -$2.87 M |
| Dec 2018 | -$7.73 M | - | - |
FAQ
- What is Vivos Therapeutics annual EBITDA?
- What is the all time high annual EBITDA for Vivos Therapeutics?
- What is Vivos Therapeutics annual EBITDA year-on-year change?
- What is Vivos Therapeutics quarterly EBITDA?
- What is the all time high quarterly EBITDA for Vivos Therapeutics?
- What is Vivos Therapeutics quarterly EBITDA year-on-year change?
- What is Vivos Therapeutics TTM EBITDA?
- What is the all time high TTM EBITDA for Vivos Therapeutics?
- What is Vivos Therapeutics TTM EBITDA year-on-year change?
What is Vivos Therapeutics annual EBITDA?
The current annual EBITDA of VVOS is -$16.68 M
What is the all time high annual EBITDA for Vivos Therapeutics?
Vivos Therapeutics all-time high annual EBITDA is -$7.73 M
What is Vivos Therapeutics annual EBITDA year-on-year change?
Over the past year, VVOS annual EBITDA has changed by +$7.69 M (+31.55%)
What is Vivos Therapeutics quarterly EBITDA?
The current quarterly EBITDA of VVOS is -$2.50 M
What is the all time high quarterly EBITDA for Vivos Therapeutics?
Vivos Therapeutics all-time high quarterly EBITDA is -$1.22 M
What is Vivos Therapeutics quarterly EBITDA year-on-year change?
Over the past year, VVOS quarterly EBITDA has changed by $0.00 (0.00%)
What is Vivos Therapeutics TTM EBITDA?
The current TTM EBITDA of VVOS is -$11.91 M
What is the all time high TTM EBITDA for Vivos Therapeutics?
Vivos Therapeutics all-time high TTM EBITDA is -$2.87 M
What is Vivos Therapeutics TTM EBITDA year-on-year change?
Over the past year, VVOS TTM EBITDA has changed by $0.00 (0.00%)